PP2A-activating drugs selectively eradicate TKI-resistant chronic myeloid leukemic stem cells
収録刊行物
-
- Journal of Clinical Investigation
-
Journal of Clinical Investigation 123 (10), 4144-4157, 2013-09-03
American Society for Clinical Investigation
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1360292621210505088
-
- DOI
- 10.1172/jci68951
-
- ISSN
- 00219738
-
- データソース種別
-
- Crossref